NASDAQ · HYPD

Hyperion DeFi, Inc.

$2.56 +$0.05 (+1.99%) 1D After hours

Key Metrics

$38.05M
Market cap
P/E · TTM
$1.04M
Revenue · TTM
−$32.99M
Net income
EPS · TTM $-15.07
Dividend yield
Free cash flow
Beta · 1Y 3.19
EBITDA · TTM
Gross margin 70.9%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    From its May 5 high, the share price fell 46%.

    Peak close $4.67 on May 5; trough close $2.51 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -46%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 6
    The stock moved -22.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 6
  • Feb 6
    The stock moved +19.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$38.05M
Enterprise value
Shares outstanding15.2M
52-wk range$2.49 – $15.00
Avg volume · 20D551.8K
Net cash
Book value / share$26.72
IndustryPharmaceutical Preparations
ExchangeNASDAQ
About Hyperion DeFi, Inc.
IPO dateJan 25, 2018
Employees9

Hyperion DeFi Inc is a USA-based company building a long-term strategic treasury of Hyperliquid's native token, HYPE.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S36.48
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 70.9%
Operating -3,351.7%
Net -3,163.0%
FCF
ROE / ROIC -56.4% · —

Financial Health

Current ratio1.97
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$4.33M

Cash Flow · TTM

Operating CF −$14.52M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

-4.2
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings